MARKET WIREReuters • 2h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
Why PLSE Stock surged +3.37% Today — RQD Quant Desk Flash
$55.48 +3.37% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $55.71
Pulse Biosciences Inc (PLSE) carries a Roarable Rating of D- (Sell) with 41/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $3.96B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $55.71 (+0.42%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (41/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-7.6% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PLSE)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (41/100 Composite)
🔍 WHY PLSE SCORES 41/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (34% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: Macro Regime Fit+10/20 pts (24% of score)
FRED Regime × Technicals: 93% of 52W Range • RSI-14 at 53.1 (NEUTRAL RANGE)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$53.81-17.4% Next Q
33
Q2 (-2Q)Grade E$44.43+19.3% Next Q
36
Q3 (-1Q)Grade E$53.02+4.6% Next Q
38
CurrentGrade D-$55.48-7.2% Hist 90D α
41
Trajectory: E (33) → D- (41)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a PLSE Turnaround Squeeze
While PLSE currently carries a cautious 41/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($51.08) and Max Pain ($58.25) forces dealer call-delta covering toward $61.84.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $PLSE• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PLSE Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why PLSE Stock surged +3.37% Today — RQD Quant Desk Flash
Pulse Biosciences Inc (PLSE) surged +3.37% to $55.48, trading at 93% of its 52-week range ($12.56 – $58.9). Stretched risk/reward at current multiples (-31% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 93% of its 52-week range ($12.56 – $58.9) with RSI-14 at 53.1 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $55.48 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 0% gross margin and $0 annual free cash flow.
Live PLSE Headlines & Catalysts
MARKET WIRECNBC • 4h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 4h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 5h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 7h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 7h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 8h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 8h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PLSE)
- ✓Walkthrough of PLSE's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
PLSE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +162.07%▲ ASCENDING CHANNEL
2026-10-30O $54.33H $55.48L $51.39C $55.48VOL 466.4K
RES: $75.93SUP: $46.10SMA50: $51.08SMA200: $31.35
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
PLSE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on PLSE today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for PLSE. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PLSE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PLSE)
Health Care Rank #602 of 1016
⚔️ NVST vs PLSE Full Matrix →
1. Head-to-Head Health Care Peer Comparison (PLSE vs. NVST, IRTC, ICUI, ATRC)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Pulse Biosciences Inc (PLSE) ranks #602 by composite RQD confidence (41/100, grade D-) and #184 by equity capitalization ($3.96B). Within this direct 5-issuer industry benchmark cohort, NVST leads on earnings valuation at 84.1x trailing P/E, while NVST leads on capital efficiency and profitability with 5.1% ROIC and 54.7% gross margin. ATRC currently holds the highest overall quantitative score in the immediate peer group at 63/100 (C) compared with PLSE at 41/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| PLSE
ACTIVE
Pulse Biosciences Inc | D- | 41/100 | — | -30.0% | -30.7% | +3.37% | $3.96B | Benchmark Subject |
| NVST Envista Holdings Corporation | D | 49/100 | 84.1x | 54.7% | 5.1% | +2.80% | $3.95B | /nvst-vs-plse → |
| IRTC iRhythm Holdings Inc. | D | 48/100 | — | 70.6% | -13.5% | +3.07% | $4.21B | /irtc-vs-plse → |
| ICUI ICU Medical Inc. | D+ | 55/100 | — | 36.8% | 1.0% | +1.36% | $4.22B | /icui-vs-plse → |
| ATRC AtriCure Inc. | C | 63/100 | — | 75.0% | -1.9% | +1.73% | $3.18B | /atrc-vs-plse → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001625101In its most recent audited fiscal period (FY2025, filed 2025-12-31), Pulse Biosciences Inc (PLSE) reported GAAP revenue of $350.0K (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$72.8M, operating cash flow of -$54.1M, and free cash flow of -$54.4M (-49.3% YoY). On the balance sheet, PLSE closed FY2025 with $94.5M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $350.0K | -$72.8M | -$54.1M | -$54.4M | $94.5M | — |
| FY2024 (FY) | 2024-12-31 | $0 | -$53.6M | -$36.3M | -$36.5M | $132.5M | — |
| FY2023 (FY) | 2023-12-31 | $0 | -$42.2M | -$33.0M | -$33.0M | — | — |
3. PLSE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs PLSE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Pulse Biosciences Inc (NASDAQ: PLSE) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 41/100 at a spot price of $55.48 (+3.37% 1D, market cap $3.96B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, PLSE ranks #602 in composite RQD confidence.
How does PLSE compare to NVST and IRTC in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), PLSE carries a Roarable D- (41/100 RQD), trailing P/E of N/A, gross margin of -30.0%, and ROIC of -30.7%. By comparison, NVST (Envista Holdings Corporation) holds a D grade (49/100 RQD, P/E 84.1x, ROIC 5.1%, cap $3.95B) and IRTC (iRhythm Holdings Inc.) posts a D grade (48/100 RQD, P/E N/A, ROIC -13.5%, cap $4.21B). Among the 5-stock peer group, NVST leads on earnings multiple (84.1x) while NVST leads on capital efficiency (5.1% ROIC).
What are the biggest fundamental strengths and SEC risk factors for PLSE?
Per PLSE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001625101), Pulse Biosciences Inc generated $350.0K in revenue, -$72.8M in net income, and -$54.4M in free cash flow against $94.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is PLSE trading relative to its 50-day, 200-day, and 52-week technical levels?
PLSE last traded at $55.48 (+3.37% on volume of 344,703 shares), positioning the stock +8.61% above its 50-day simple moving average ($51.08) and +76.97% above its 200-day simple moving average ($31.35). Across its 52-week range of $12.56 to $58.90, PLSE sits at the 92.6% percentile with a 14-day RSI of 53.1 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($48.55 to $62.41).
PLSE Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is PLSE stock moving today?
Why PLSE Stock surged +3.37% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-31% return on capital) under elevated 10-year interest-rate pressure.